Sean Stalfort
Director, Dova Pharmaceuticals Inc.
Companies
- Taysha Gene Therapies, Inc.Board member Jun 26, 2023 to now1
- Acumen Pharmaceuticals, Inc.Board member Jun 30, 2021 to now2
- Verrica Pharmaceuticals Inc.Board member Jun 14, 2018 to Nov 26, 20243
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Taysha Gene Therapies, Inc. TSHA2,060,849 shares4$7.8M at $3.77Jun 2, 2026
- Verrica Pharmaceuticals Inc. VRCA1,873,800 shares5$7.1M at $3.81Nov 26, 2024
- Acumen Pharmaceuticals, Inc. ABOS220,624 shares6$372.9K at $1.69Jun 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2026Granted 35,500 shares of Acumen Pharmaceuticals, Inc.6
- Jun 1, 2026Granted 21,335 shares of Taysha Gene Therapies, Inc.4
- Jun 4, 2025Granted 12,800 shares of Acumen Pharmaceuticals, Inc.7
- Jun 2, 2025Granted 56,623 shares of Taysha Gene Therapies, Inc.8
- Nov 26, 2024Gift 50,000 shares of Verrica Pharmaceuticals Inc.5
- Nov 22, 2024Bought 1,123,595 shares of Verrica Pharmaceuticals Inc.5
- May 29, 2024Granted 49,220 shares of Taysha Gene Therapies, Inc.9
- Aug 16, 2023Gift 50,000 shares of Taysha Gene Therapies, Inc.10
- Aug 16, 2023Bought 388,889 shares at $0.90 of Taysha Gene Therapies, Inc.10
- Aug 16, 2023Bought 388,889 shares at $0.90 of Taysha Gene Therapies, Inc.10
- Jul 5, 2022Bought 238,095 shares at $2.10 of Verrica Pharmaceuticals Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 5, 2025
- 8SEC EDGARForm 4 filed Jun 4, 2025
- 9SEC EDGARForm 4 filed May 31, 2024
- 10SEC EDGARForm 4 filed Aug 16, 2023
- 11SEC EDGARForm 4 filed Jul 5, 2022